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In healthy subjects, nutritional ‘equilibrium’ is maintained by the
oral intake of substrates providing energy, structural integrity and
body regulation (vitamins, minerals, etc). Any reduction in intake
of these elements, especially when combined with the metabolic
abnormalities observed in patients with cancer, leads to an
imbalance resulting in progressive malnutrition. This is generally
a protein–calorie malnutrition, often accompanied by deficits in
specific nutrients. The prevalence of malnutrition is dependent on
the tumour site and its stage. Malnutrition is more prevalent in
patients with cancer of the proximal gastrointestinal tract.
Malnutrition can be due to several factors:
 Reduced intake due to difficulties in eating, pain, mechanical
obstruction and occasionally psychological disturbances.
 Metabolic changes induced by the tumour.
 Modification of energy expenditure.
OBJECTIVES
The objective of this document is to define the ‘Standards’, ‘Options’
and ‘Recommendations’ (SORs) for nutritional assessment in adults
with cancer and to describe the nutritional assessment tools for use
in daily practice. Experimental and/or high-technology techniques,
techniques for evaluating specific nutrient deficits and the
investigation of organic or functional gut dysfunction are not
covered here. The nutritional assessment of children is not covered
in this document. Management of malnutrition and nutritional
support techniques is covered in other specific SOR documents.
This document will not aim to explain in detail the physiopathology
of malnutrition in patients with cancer.
METHODOLOGY
The general methodology used has already been described (Fervers
et al, 2001). For this specific SOR, a working group of dietitians set
up by the French National Federation of Cancer Centres
(Fe ´deration Nationale des Centres de Lutte Contre le Cancer;
FNCLCC) reviewed the best available evidence on the nutritional
assessment of patients with cancer.
A literature search was performed in Medline
s up to March
1999 using the following terms: nutrition assessment, nutritional
status, neoplasms. The references thus identified were completed
by members of the working group from their personal reference
lists. After selection and critical appraisal of this literature, the
working group defined the ‘Standards’, ‘Options’ and ‘Recommen-
dations’ for nutritional assessment of patients with cancer, based
on a synthesis of the best available evidence.
When all the members of the working group agree, based on the
best available evidence, that a procedure or intervention is
beneficial, inappropriate or harmful, it is classified as a ‘Standard’,
and when the majority agree, it is classified as an ‘Option’ (Table 1).
In the SORs, there can be several ‘Options’ for a given clinical
situation. ‘Recommendations’ provide additional information that
enable the available options to be ranked using explicit criteria
(e.g. survival, toxicity) with an indication of the level of evidence.
These recommendations thus help clinicians to select an appro-
priate option. Thus, clinicians can make choices for the manage-
ment of patients using this information and taking into
consideration local circumstances, skills, equipment, resources
and/or patient preferences. The adaptation of the SOR to the local
situation is allowable if the reason for the choice is sufficiently
transparent, and this is crucial for successful implementation.
Inclusion of patients in clinical trials is an appropriate form of
patient management in oncology and is recommended frequently
within the SORs, particularly in situations where only weak
evidence exists to support a procedure or an intervention.
The type of evidence underlying any ‘Standard’, ‘Option’ or
‘Recommendation’ is indicated using a classification developed by
the FNCLCC based on previously published methods. The
level of evidence depends not only on the type and quality
of the studies reviewed, but also on the concordance of the results
(Table 2). When no clear scientific evidence exists, judgement is
made according to the professional experience and consensus
of the expert group (‘expert agreement’), and this is then validated
by the peer-review process.
The working group drafted the full text version of the
‘Standards’, ‘Options’ and ‘Recommendation’. This version was
then peer-reviewed by independent experts, whose comments were
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August 1999. The French summary version was prepared from the
full text version and this is translated into English here. These
documents will be updated when new scientific data become
available or if there is a change in expert agreement.
This summary version is based on the full version (Duguet et al,
1999) and is also available on the FNCLCC web site: http://
www.fnclcc.fr
EFFECT OF ANTITUMOUR TREATMENT ON
NUTRITION
Surgery induces metabolic changes that can be worsened by
infectious complications thus increasing malnutrition. After major
gastrointestinal surgery, the availability of nutrients can be
reduced and oral food intake is lower. Hypercatabolism can occur
in the perioperative phase. Increased mortality, local morbidity
and infectious complications are observed in patients with severe
malnutrition.
Chemotherapy can affect mucous membranes (mucositis) and
can induce nausea, vomiting, anorexia and/or diarrhoea leading to
reduced food intake. Hypercatabolism is sometimes seen in
patients who undergo high-dose chemotherapy with peripheral
blood stem cell support.
Radiotherapy has direct short-term and long-term effects on
olfactory and secretory function, the digestive tract and the
mucous membranes. Long-term bone, dental, olfactory, secretory
and digestive sequelae can lead to reduced food intake and/or
malabsorption of nutrients.
CONSEQUENCES OF MALNUTRITION IN PATIENTS
WITH CANCER
Malnutrition in patients with cancer is associated with a
deterioration in quality of life and increased perioperative
morbidity and mortality following major surgery. It can also lead
to a lower response to treatment.
NUTRITIONAL ASSESSMENT: CLINICAL AND
ANTHROPOMETRIC DATA
The clinical and anthropometric assessment should include the
measurement of height and weight, premorbid weight, amount and
rate of weight loss, a calculation of body-mass index, collection of
socioeconomic data, assessment of any digestive disorders, clinical
examination and calculation of energy requirements (standard).
The assessment can be completed by the measurement of skin fold
thickness (option) or the mid-arm muscle circumference (option).
Nutritional support is recommended when patients have lost more
than 10% of their usual body weight over 6 months (recommenda-
tion). The World Health Organization (WHO) scale should be used
to evaluate the toxicity of anticancer treatments on the digestive
tract (recommendation, expert agreement).
ASSESSMENT OF FOOD INTAKE
The assessment of food intake should include the calculation of the
calorie–nitrogen ratio consumed (standard) using one of two
techniques: dietary recall and dietary record (option).
ASSESSMENT OF THE MODIFICATION OF FUNC-
TIONAL CAPACITIES
Functional capacity can be assessed using one of two validated
tools: WHO performance status or the Karnofsky index (option).
The same tool should be used throughout.
CLINICAL AND NUTRITIONAL SCORES
Multidimensional clinical and nutritional assessment can be
performed using scores based on one of the three validated scales:
Detsky’s subjective global assessment; the self-administered global
assessment; and the mini nutritional assessment in elderly patients
(option).
Table 1 Definition of Standards, Options and Recommendations
Standards Procedures or treatments that are considered to be of benefit, inappropriate or harmful by unanimous decision, based on the best available
evidence
Options Procedures or treatments that are considered to be of benefit, inappropriate or harmful by a majority, based on the best available evidence
Recommendations Additional information to enable the available options to be ranked using explicit criteria (e.g. survival, toxicity) with an indication of the level of
evidence
Table 2 Definition of level of evidence
Level A
There exists a high-standard meta-analysis several high-standard randomised clinical trials which give consistent results
Level B
There exist good quality evidence from randomised trials (B1) or prospective or retrospective studies (B2). The results are consistent when considered together
Level C
The methodology of the available studies is weak or their results are not consistent when considered together
Level D
Either the scientific data do not exist or there is only a series of cases
Expert agreement
The data do not exist- for the method concerned, but the experts are unanimous in their judgement
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Assays for albumin, prealbumin (or transthyretin), transferrin and
retinol binding proteins can be used as biological markers for
malnutrition in patients with no ongoing inflammatory condition
(option). The predictive value of each individual parameter alone
is not sufficient. Risk scores, combining several parameters,
should be used (recommendation). Four tools are available for
this: the prognostic inflammatory and nutritional index, the
nutritional risk index, the prognostic nutritional risk and the aid
for decision for nutritional support score (option). Functional and
objective measurements can be made (bioelectric impedance
analysis and calorimetry) for the follow-up and assessment of
the degree of malnutrition and/or to assess metabolic requirements
(option).
MINIMUM ROUTINE NUTRITIONAL ASSESSMENT
FIGURE 1)
The minimum routine nutritional assessment should include
clinical history taking, measurement of the current height and
weight, premorbid body weight, and the assessment of weight
changes and dietary intake by a dietitian (standard). An
assessment of functional capacity using a validated scale (WHO
or Karnofsky) and an assessment of gastrointestinal disorders
Adult patient with cancer
initial consulation or hospitalisation
Minimal nutritional assessment
Standards
· Measurement of height
· Measurement of actual body weight
· Collection of socioeconomic data, medical history, current
   treatments
· Assessment of dietary intake
· Assessment of energy requirements
· Clinical examination
· Determination of premorbid body weight
· Calculation of the Quetelet index
· Assessment of weight change over time
Options
· Assessment of functional capacity with Karnofsky's
   scale or the WHO performance status
· Assessment of gut problems with the specific WHO scale
Recommendation
Weight change should be measured as
a percentage of weight loss over a period of time
Patient with malnutrition or at risk
of malnutrition?
Standard
There is no standard 
Recommendation
Assessment depending on nutritional
status and therapeutic programme
Standard
There is no standard 
Options
· No additional assessment
· Collection of additional data
Optional
assessment
Figure 3
Additional
assessment
Figure 2
Yes No


Figure 1 Minimal nutritional assessment.
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over a given period, should be measured and presented as a
percentage of weight loss compared with the premorbid body
weight (recommendation).
ADDITIONAL NUTRITIONAL ASSESSMENT
(FIGURES 2 AND 3)
Additional nutritional assessment can be undertaken depending
on the patient and their treatment. Detsky’s subjective global
assessment or Buzby’s nutritional risk index should be used for
patients undergoing major surgery (standard).
For patients who suffer from malnutrition, the assessment can
be complemented by Detsky’s subjective global assessment or
Buzby’s nutritional risk index (option).
In patients who suffer from malnutrition or who have under-
gone major surgery, the work-up can include an albumin and/or
prealbumin assay and an assay for inflammatory proteins
(orosomucoids, C-reactive protein) for the calculation, for
example, of the prognostic inflammatory and nutritional index
(option).
A mini nutritional assessment can be used in the work-up and
follow-up of elderly patients (option).
FOLLOW-UP OF NUTRITIONAL MANAGEMENT
(FIGURE 4)
Follow-up of the efficacy of the nutritional management should
include regular weight measurement, plus an examination for
oedema or ascites (standard). The calorie–nitrogen ratio intake
should be determined regularly (standard). Follow-up of the
efficacy of nutritional management can include the determination
of serum albumin and prealbumin concentrations, a calculation of
the prognostic inflammatory and nutritional index, and an
assessment of any improvement in the patients’ functional capacity
and/or dynamometry (option). The patient’s inflammatory state
should be taken into consideration when interpreting albumin
levels and the prognostic inflammatory and nutritional index
Additional nutritional assessment
Patients with
malnutrition
Patients undergoing
major surgery
Elderly patients Patients receiving
long-term artificial
nutrition
Standard
There is no standard
Options
· Assess extent of malnutrition
   with Detsky's SGA*
· Assessment of laboratory
   parameters: albumin and 
   prealbumin
Recommendation
Nutritional support for patients
who have lost more than 10% of 
premorbid body weight
Standard
There is no standard
Options
· Detsky SGA*
· Buzby's index
· Assessment of laboratory
   parameters: albumin and
   prealbumin
Standard
There is no standard
Option
MNA questionnaire**
Standard
There is no standard
Options
· Indirect calorimetry
· Skin fold measurement
· Mid-arm muscle
   circumference
· Bioelectric impedance 
   analysis
Recommendation
Determine calorie intake
using reliable
calorimeteric data
Optional
assessment
Figure 3
*Detsky's subjective global assessment.
**Mini Nutritional Assessment questionnaire.

Figure 2 Additional nutritional assessment.
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efficacy of the nutritional management can be assessed by
measuring skin fold thickness and the mid-arm muscle circum-
ference and by bioelectrical impedance analysis (options).
Regular assessment of the functional consequences of the cancer
and any malnutrition is recommended. The concentration of
prealbumin is the biological parameter that probably enables the
quickest assessment of any nutritional improvement. In patients
undergoing prolonged artificial nutrition, the calorie–nitrogen
requirement should be calculated using data obtained from
indirect calorimetry. Anthropometric measurements can be used
to assess the efficacy of artificial nutrition.
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Optional nutritional assessment
Standard
There is no standard
Options
· No additional work-up
· Skin fold measurement
· Mid-arm muscle circumference measurement
· Detsky's index
· Self-administerd subjective global assessment
· Mini Nutritional Assessment (MNA) for elderly patients
· Albumin assay
· Prealbumin assay
· Transferrin assay
· Retinol binding protein assay
· Prognostic Inflammatory and Nutritional Index (PINI)
· Buzby's index
· Prognostic Nutritional Index (Mullen)
· Decision aid for nutritional support score
· Bioelectric impedance analysis
· Calorimetry
Nutritional
follow-up
Figure 4

Figure 3 Optional nutritional assessment.
Nutritional follow-up
Standards 
· Regular weight measurement
· Search for oedema and/or ascites
· Calculation of the ingested calorie–nitrogen ratio
Options 
· Assays for albumin and prealbumin
· Prognostic Inflammatory and Nutritional Index (PINI)
· Assessment of improvement in functional capacity
Recommendations
· Regular assessment of the functional consequences of the
   illness and the malnutrition
· Prealbumin concentration is the quickest means of detecting
   nutritional improvement
· For patients receiving prolonged artificial nutrition,
   calorie – nitrogen requirements should be calculated using
   data obtained from indirect calorimetry
· Anthropometric measurements can be used to assess the
   efficacy of artificial nutrition
Figure 4 Nutritional follow-up.
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